Lv4
584 积分 2024-10-29 加入
Cyclin dependent kinase (CDK) inhibitors as anticancer drugs
1个月前
已完结
The expanding repertoire of covalent warheads for drug discovery
1个月前
已完结
Discovery of N1-(4-((7-Cyclopentyl-6-(dimethylcarbamoyl)-7H-pyrrolo[2,3-d]pyrimidin-2-yl)amino)phenyl)-N8-hydroxyoctanediamide as a Novel Inhibitor Targeting Cyclin-dependent Kinase 4/9 (CDK4/9) and Histone Deacetlyase1 (HDAC1) against Malignant Cancer
1个月前
已完结
Biomarkers of response to neoadjuvant palbociclib plus anastrozole in endocrine-resistant estrogen receptor-positive/HER2-negative breast cancer: a phase 2 trial
3个月前
已完结
Recent Study of Dual HDAC/PARP Inhibitor for the Treatment of Tumor
3个月前
已完结
Tumour hypoxia in driving genomic instability and tumour evolution
4个月前
已完结
Turning cold into hot: emerging strategies to fire up the tumor microenvironment
4个月前
已完结
Towards targeting of shared mechanisms of cancer metastasis and therapy resistance
4个月前
已完结
Tunable Cysteine-Targeting Electrophilic Heteroaromatic Warheads Induce Ferroptosis
4个月前
已完结
Development of a Highly Selective Ferroptosis Inducer Targeting GPX4 with 2-Ethynylthiazole-4-carboxamide as Electrophilic Warhead
4个月前
已完结
皖公网安备34019202002308
